by Jason Heaviland | Mar 2, 2026
Chemical Exposure Profiling of Alzheimer’s Patients This webinar presents a comprehensive overview of chemical exposure profiling in Alzheimer’s patients using Panome Bio’s Targeted Exposomics™ and Discovery Exposomics™ platforms. Learn how quantitative exposure...
by Jason Heaviland | Jan 12, 2026
Payload to Patient: Metabolomics in ADC and Immuno-Oncology In this episode of the ChatGJP series, Panome Bio CSO Dr. Gary J. Patti joins Chris Eden to explore real-world applications of metabolomics in antibody–drug conjugates (ADCs) and immuno-oncology. The...
by Jason Heaviland | Dec 9, 2025
ChatGJP: LC-MS Proteomics, Multi-Omics, & Precision Medicine In this episode of the ChatGJP series, Panome Bio CSO Dr. Gary J. Patti discusses the strengths and limitations of LC–MS–based proteomics compared to affinity-based approaches, highlighting why mass...
by Janine Rodriguez | Nov 25, 2025
ChatGJP: Insights from Gary Patti on Mass Spec and Multi-Omics In this episode of the ChatGJP series, Panome Bio CSO Gary Patti shares candid insights into his research at Washington University in St. Louis, his work with Panome Bio, and the evolving landscape of mass...
by Jason Heaviland | Nov 6, 2025
Inside PRMT5: Metabolomics-Driven Insights for Cancer Therapy PRMT5 is a promising therapeutic target, especially in MTAP-deleted tumors, but measuring its inhibition has remained a challenge. In this webinar, Panome Bio scientists introduce a targeted metabolite...
